We are live on ! Find out more
PAHC icon

Phibro Animal Health

155 hedge funds and large institutions have $517M invested in Phibro Animal Health in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

17% more capital invested

Capital invested by funds: $441M → $517M (+$75.9M)

1% more funds holding

Funds holding: 153155 (+2)

7% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 55

0.59% more ownership

Funds ownership: 101.81%102.4% (+0.59%)

Holders
155
Holders Change
+2
Holders Change %
+1.31%
% of All Funds
3.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
59
Reduced
55
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
26
Martingale Asset Management
Massachusetts
$4.14M +$1.77M +76,115 +84%
SDIC
27
South Dakota Investment Council
South Dakota
$3.87M +$1.02M +43,842 +39%
Invesco
28
Invesco
Georgia
$3.81M +$113K +4,866 +3%
Citadel Advisors
29
Citadel Advisors
Florida
$3.58M +$2.07M +89,074 +162%
MSL
30
Mackay Shields LLC
New York
$3.41M +$76.6K +3,300 +2%
CVA
31
Ceredex Value Advisors
Florida
$3.37M -$1.5M -64,685 -32%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$3.33M
MAM
33
Madison Asset Management
Wisconsin
$3.32M +$3.1M +133,646 New
AQR Capital Management
34
AQR Capital Management
Connecticut
$3.18M -$336K -14,496 -10%
Charles Schwab
35
Charles Schwab
California
$3.07M +$10.9K +470 +0.4%
Ameriprise
36
Ameriprise
Minnesota
$3.02M -$477K -20,542 -14%
Bank of America
37
Bank of America
North Carolina
$2.99M -$138K -5,947 -5%
Norges Bank
38
Norges Bank
Norway
$2.48M -$3.18M -137,000 -58%
JP Morgan Chase
39
JP Morgan Chase
New York
$2.38M -$700K -30,150 -24%
PPA
40
Parametric Portfolio Associates
Washington
$2.27M +$1.37M +58,944 +182%
WG
41
Winton Group
United Kingdom
$2.16M +$756K +32,558 +60%
FP
42
Factorial Partners
New York
$2.11M +$1.1M +47,500 +109%
QI
43
QS Investors
New York
$2.01M -$24.1K -1,040 -1%
Two Sigma Investments
44
Two Sigma Investments
New York
$1.98M +$906K +39,036 +96%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$1.95M +$1.17M +50,339 +178%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$1.94M +$246K +10,600 +16%
BCC
47
Bridge City Capital
Oregon
$1.91M +$524K +22,598 +41%
RJA
48
Raymond James & Associates
Florida
$1.7M +$1.59M +68,487 New
DCM
49
Dupont Capital Management
Delaware
$1.65M +$612K +26,387 +66%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$1.64M +$65.9K +2,838 +4%

PAHC Hedge Fund Activity: Q4 2019 in Review

155 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2019, worth a combined $517M — up 17% from $441M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PAHC positions and 16 closed out — a net gain of 3 holders — while 59 added to existing stakes and 55 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $18.1M. The largest seller was Janus Henderson Group, cutting an estimated $3.68M.

  • 155 institutional investors held Phibro Animal Health (PAHC) as of Q4 2019, up from 153 in Q3 2019.
  • Funds reported $517M of Phibro Animal Health stock for Q4 2019, up 17% quarter-over-quarter.
  • 19 funds opened new Phibro Animal Health positions in Q4 2019 and 16 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q4 2019 was Principal Financial Group, an estimated $18.1M added.
  • The largest Phibro Animal Health seller in Q4 2019 was Janus Henderson Group, an estimated $3.68M sold.

Based on aggregated 13F filings for Q4 2019.